Advertisement

Topics

Teva Pharmaceutical Industries Limited (TEVA) Lowered to Strong Sell at BidaskClub

13:09 EDT 16 Aug 2017 | Topix

Other equities analysts also recently issued reports about the stock. Citigroup Inc. downgraded shares of Teva Pharmaceutical Industries Limited from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $32.00 to $19.00 in a report on Wednesday.

Original Article: Teva Pharmaceutical Industries Limited (TEVA) Lowered to Strong Sell at BidaskClub

NEXT ARTICLE

More From BioPortfolio on "Teva Pharmaceutical Industries Limited (TEVA) Lowered to Strong Sell at BidaskClub"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...